Newswire (Published: Monday, March 20, 2017, Received: Thursday, March 16, 2017, 12:23:37 PM CDT)

Word Count: 507

Case Western Reserve University Reports Findings in Prostate Cancer (Is a behavioral treatment for urinary incontinence beneficial to prostate cancer survivors as a follow-up care?)

By a News Reporter-Staff News Editor at Clinical Trials Week -- Investigators discuss new findings in Oncology - Prostate Cancer. According to news reporting out of Cleveland, Ohio, by NewsRx editors, research stated, "The American Cancer Society (ACS) recommends a follow-up care plan for urinary incontinence of prostate cancer survivors that includes pelvic floor muscle exercise (PFME). We examined potential impacts and access barriers of this recommendation with consideration of patients who normally do not seek such care."

Our news journalists obtained a quote from the research from Case Western Reserve University, "We compared 267 participants of a clinical trial that tested a PFME-based treatment of urinary incontinence and 69 nonparticipants who declined the trial. All subjects were assessed at baseline, 3, and 6 months on leakage frequency, disease-specific quality of life (QOL), and physical well-being. The nonparticipants were interviewed to examine reasons for intervention refusal. The participating and nonparticipating groups did not differ in most baseline demographics and clinical variables except that the nonparticipants had lower baseline prostate-specific antigen (P ae <currency > 0.01), lower education levels, and higher likelihood of receiving surgery alone (both P ae <currency > 0.05). Nonparticipants exhibited significantly more frequent daily leakage, poorer urinary function and bother, and severer urinary problems at 3 and 6 months, as well as worse physical well-being at 6 months, relative to baseline, than the participants. The primary reason for refusal was economical, such as lacking transportation and time for participation. Urinary function and QOL can worsen without appropriate follow-up care. It is important to make a PFME-based follow-up care program available to all incontinent prostate cancer survivors as recommended by ACS guidelines."

According to the news editors, the research concluded: "Seeking PFME-based treatment is crucial for long-term urinary health outcomes even if present leakage is minor or financial challenge is a concern."

For more information on this research see: Is a behavioral treatment for urinary incontinence beneficial to prostate cancer survivors as a follow-up care? Journal of Cancer Survivorship, 2017;11(1):24-31. Journal of Cancer Survivorship can be contacted at: Springer, 233 Spring St, New York, NY 10013, USA. (Springer - www.springer.com; Journal of Cancer Survivorship - www.springerlink.com/content/1932-2259/)

Our news journalists report that additional information may be obtained by contacting A.Y. Zhang, Case Western Reserve University, Sch Nursing, Cleveland, OH 44106, United States. Additional authors for this research include A.Z. Fu, S. Moore, H. Zhu, G. Strauss, D. Kresevic, E. Klein, L. Ponsky and D.R. Bodner (see also Oncology - Prostate Cancer).

Keywords for this news article include: Cleveland, Ohio, United States, North and Central America, Urologic Diseases and Conditions, Cancer, Epidemiology, Urinary Incontinence, Prostatic Neoplasms, Prostate Cancer, Oncology, Urology, Case Western Reserve University.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC

Companies

American Cancer Society Inc.
Case Western Reserve University

Places

Central America
North America
United States
Americas
New York
Ohio
New York City
Cleveland

Subjects

Science and Technology
      Scientific Research
Health and Wellness
      Medical Conditions and Diseases
            Cancer
                  Prostate Cancer
            Men's Health Issues
                  Prostate Cancer
            Urological Diseases
      Medical Specialties and Practices
            Urology
      Medical and Pharmaceutical Regulation
            Drug and Device Approval Process
Life and Society
      Education
            Academic Levels